Activity and Metabolism of 2-β-d-Ribofuranosylthiazole-4-carboxamide in Human Lymphoid Tumor Cells in Culture

作者: Robert I. Glazer , Martin F. Earle

DOI:

关键词:

摘要: The antitumor activity of the C-nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (TR), was investigated in four human lymphoid tumor cell lines culture. Exposure CCRF-CEM (T-cell leukemia), HUT-78 (cutaneous T-cell lymphoma), NALM-1 (B-cell and MOLT-4 leukemia) for 72 hr to TR resulted 50% inhibitory concentration 30, 27, 7, 6 microM, respectively. Maximum inhibition DNA RNA synthesis occurred after drug treatment. among varied from 5 8 microM 4 synthesis. Nucleotide analyses cells exposure 10 100 revealed increased inosine 5'-monophosphate concentrations which were 18- 20-fold greater than control levels a parallel reduction 82 100% guanosine concentrations. Growth by almost fully reversible addition 50 medium 18 hr. Analyses high-pressure liquid chromatography two metabolites all lines, namely, thiazolecarboxamide riboside adenine dinucleotide, latter is potent inhibitor inosine-5-'-monophosphate dehydrogenase. These results suggest that effects may relate guanine nucleotide depletion.

参考文章(11)
M.B. Cohen, J. Maybaum, W. Sadee, Guanine nucleotide depletion and toxicity in mouse T lymphoma (S-49) cells. Journal of Biological Chemistry. ,vol. 256, pp. 8713- 8717 ,(1981) , 10.1016/S0021-9258(19)68902-7
L Brox, J F Henderson, J K Lowe, Consequences of Inhibition of Guanine Nucleotide Synthesis by Mycophenolic Acid and Virazole Cancer Research. ,vol. 37, pp. 736- 743 ,(1977)
Hiremagalur N. Jayaram, David A. Cooney, Robert I. Glazer, Robert L. Dion, David G. Johns, Mechanism of resistance to the oncolytic C-nucleoside 2-β-D-ribofuranosylthiazole-4-carboxamide (NSC-286193) Biochemical Pharmacology. ,vol. 31, pp. 2557- 2560 ,(1982) , 10.1016/0006-2952(82)90071-5
Prem C. Srivastava, Michael V. Pickering, Lois B. Allen, David G. Streeter, Marie T. Campbell, Joseph T. Witkowski, Robert W. Sidwell, Roland K. Robins, Synthesis and antiviral activity of certain thiazole C-nucleosides. Journal of Medicinal Chemistry. ,vol. 20, pp. 256- 262 ,(1977) , 10.1021/JM00212A014
Gary W. Zieve, Two groups of small stable RNAs Cell. ,vol. 25, pp. 296- 297 ,(1981) , 10.1016/0092-8674(81)90046-5
Hiremagalur N. Jayaram, Antoinette L. Smith, Robert I. Glazer, David G. Johns, David A. Cooney, Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193)-II. Relationship between dose level and biochemical effects in P388 leukemia in vivo Biochemical Pharmacology. ,vol. 31, pp. 3839- 3845 ,(1982) , 10.1016/0006-2952(82)90300-8
Hiremagalur N. Jayaram, Robert L. Dion, Robert I. Glazer, David G. Johns, Roland K. Robins, Prem C. Srivastava, David A. Cooney, Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide NSC 286193) Biochemical Pharmacology. ,vol. 31, pp. 2371- 2380 ,(1982) , 10.1016/0006-2952(82)90532-9
A SHATKIN, Capping of eucaryotic mRNAs Cell. ,vol. 9, pp. 645- 653 ,(1976) , 10.1016/0092-8674(76)90128-8
Floyd F. Snyder, Rebecca J. Trafzer, Michael S. Hershfield, J.Edwin Seegmiller, Elucidation of aberrant purine metabolism. Application to hypoxanthine-guanine phosphoribosyltransferase- and adenosine kinase-deficient mutants, and IMP dehydrogenase- and adenosine deaminase-inhibited human lymphoblasts Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. ,vol. 609, pp. 492- 501 ,(1980) , 10.1016/0005-2787(80)90123-9